ATE525063T1 - Antivirale formulierung - Google Patents
Antivirale formulierungInfo
- Publication number
- ATE525063T1 ATE525063T1 AT09723439T AT09723439T ATE525063T1 AT E525063 T1 ATE525063 T1 AT E525063T1 AT 09723439 T AT09723439 T AT 09723439T AT 09723439 T AT09723439 T AT 09723439T AT E525063 T1 ATE525063 T1 AT E525063T1
- Authority
- AT
- Austria
- Prior art keywords
- weight
- treatment
- antiviral formulation
- omaciclovir
- penciclovir
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000000840 anti-viral effect Effects 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- 238000011282 treatment Methods 0.000 abstract 2
- SCBFBAWJWLXVHS-ZCFIWIBFSA-N 2-amino-9-[(2r)-4-hydroxy-2-(hydroxymethyl)butyl]-3h-purin-6-one Chemical compound N1C(N)=NC(=O)C2=C1N(C[C@H](CO)CCO)C=N2 SCBFBAWJWLXVHS-ZCFIWIBFSA-N 0.000 abstract 1
- 208000004898 Herpes Labialis Diseases 0.000 abstract 1
- 208000029433 Herpesviridae infectious disease Diseases 0.000 abstract 1
- JNTOCHDNEULJHD-UHFFFAOYSA-N Penciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(CCC(CO)CO)C=N2 JNTOCHDNEULJHD-UHFFFAOYSA-N 0.000 abstract 1
- 208000037048 Prodromal Symptoms Diseases 0.000 abstract 1
- 229960004150 aciclovir Drugs 0.000 abstract 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 229950002238 omaciclovir Drugs 0.000 abstract 1
- 229960001179 penciclovir Drugs 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08152862 | 2008-03-17 | ||
| JP2008238844A JP4972062B2 (ja) | 2008-03-17 | 2008-09-18 | 抗ウイルス製剤 |
| PCT/EP2009/053125 WO2009115510A1 (en) | 2008-03-17 | 2009-03-17 | Antiviral formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE525063T1 true ATE525063T1 (de) | 2011-10-15 |
Family
ID=39343655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT09723439T ATE525063T1 (de) | 2008-03-17 | 2009-03-17 | Antivirale formulierung |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20090270429A1 (de) |
| EP (1) | EP2278956B1 (de) |
| JP (1) | JP4972062B2 (de) |
| AT (1) | ATE525063T1 (de) |
| CA (1) | CA2717440C (de) |
| ES (1) | ES2372149T3 (de) |
| MX (1) | MX2010010089A (de) |
| WO (1) | WO2009115510A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100100060A1 (en) * | 2008-10-17 | 2010-04-22 | Novartis Ag | Applicator for pharmaceutical product and method of using same |
| EP2509586B1 (de) | 2009-12-09 | 2018-05-02 | Vectans Pharma | Mukoadhäsive bukkale tabletten zur behandlung von orofazialem herpes |
| EP2335690A1 (de) | 2009-12-09 | 2011-06-22 | BioAlliance Pharma | Mukoadhäsive bukkale Tabletten zur Behandlung von orofazialem Herpes |
| CA2829241A1 (en) | 2011-04-01 | 2012-10-04 | University Of Florida Research Foundation, Inc. | Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics |
| ITMI20111747A1 (it) * | 2011-09-28 | 2013-03-29 | Fidia Farmaceutici | Composizioni farmaceutiche topiche comprendenti aciclovir |
| WO2017029298A1 (en) * | 2015-08-17 | 2017-02-23 | Sanovel Ilac Sanayi Ve Ticaret A.S. | A topical antiviral composition |
| RU2672878C1 (ru) * | 2017-12-13 | 2018-11-20 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный химико-фармацевтический университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СПХФУ Минздрава России) | Анальгезирующее и противовирусное средство на основе 2,2'-[(6-метилпиримидин-2,4-диил)бис(3-(4-нитрофенил)-1H-1,2,4-триазол-1,5-диил)]дипропановой кислоты |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR830005852A (ko) * | 1980-07-18 | 1983-09-14 | 미첼 페터 잭슨 | 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법 |
| GB8815241D0 (en) * | 1988-06-27 | 1988-08-03 | Wellcome Found | Antiviral combinations & compounds therefor |
| GB9315755D0 (en) * | 1993-07-30 | 1993-09-15 | Wellcome Found | Stabilized formulation |
| TW438585B (en) * | 1995-02-06 | 2001-06-07 | Astra Ab | Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections |
| US5760096A (en) * | 1996-10-18 | 1998-06-02 | Thornfeldt; Carl R. | Potent penetration enhancers |
| GB9718791D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Medicaments |
| US7223387B2 (en) * | 1998-11-18 | 2007-05-29 | Medivir Ab | Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester |
| SE9803929D0 (sv) * | 1998-11-18 | 1998-11-18 | Medivir Ab | Antiviral formulation |
-
2008
- 2008-09-18 JP JP2008238844A patent/JP4972062B2/ja not_active Expired - Fee Related
-
2009
- 2009-03-13 US US12/403,665 patent/US20090270429A1/en not_active Abandoned
- 2009-03-17 CA CA2717440A patent/CA2717440C/en active Active
- 2009-03-17 AT AT09723439T patent/ATE525063T1/de not_active IP Right Cessation
- 2009-03-17 ES ES09723439T patent/ES2372149T3/es active Active
- 2009-03-17 WO PCT/EP2009/053125 patent/WO2009115510A1/en not_active Ceased
- 2009-03-17 MX MX2010010089A patent/MX2010010089A/es active IP Right Grant
- 2009-03-17 EP EP09723439A patent/EP2278956B1/de not_active Not-in-force
-
2016
- 2016-03-09 US US15/064,711 patent/US20170020882A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2717440A1 (en) | 2009-09-24 |
| MX2010010089A (es) | 2010-11-30 |
| WO2009115510A1 (en) | 2009-09-24 |
| EP2278956A1 (de) | 2011-02-02 |
| CA2717440C (en) | 2015-12-29 |
| US20090270429A1 (en) | 2009-10-29 |
| ES2372149T3 (es) | 2012-01-16 |
| US20170020882A1 (en) | 2017-01-26 |
| JP4972062B2 (ja) | 2012-07-11 |
| EP2278956B1 (de) | 2011-09-21 |
| JP2009221186A (ja) | 2009-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP13012546A (es) | Formulación tópica para un inhibidor de jak | |
| CU20130069A7 (es) | Derivados de 2,3-dihidroimidazo[1,2-c] quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermeddes asociadas a la angiogénesis | |
| NZ618734A (en) | Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas | |
| AR073123A1 (es) | Composicion farmaceutica que comprende un taxano sustancialmente amorfo para utilizarse en el tratamiento de la enfermedad neoplasica | |
| SG158870A1 (en) | Bendamustine pharmaceutical compositions for lyophilisation | |
| ECSP11011324A (es) | 3h-imidazo[4,5-c]piridina-6-carboxamidas en calidad de agentes antiinflamatorios | |
| DOP2009000135A (es) | Derivados de 2,3-dihidroimidazo [1,2-c] quinazolina sustituídos de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogénesis | |
| MX2008001503A (es) | Composicion cosmetica o dermatologica para la prevencion o el tratamiento de piel sensible o seca. | |
| MX2010004613A (es) | Composicion topica. | |
| IL201322A (en) | Use of a topical, water-free compound containing esters of organic acids in the preparation of drugs for the treatment of nail and fungal diseases and fungal diseases | |
| MY173582A (en) | Extended-release formulation for reducing the frequency of urination and method of use thereof | |
| BRPI1007945C8 (pt) | formulação farmacêutica de liberação controlada de nitazoxanida, tizoxanida ou uma combinação dos mesmos, e, comprimido de bicamada para administração oral | |
| EP2328550A4 (de) | Mukoadhärente zusammensetzungen und ihre verwendung | |
| WO2012154122A3 (en) | A topical formulation for treatment of hyperkeratotic skin | |
| GB2476446A (en) | Topical treatment of skin infection | |
| NZ718163A (en) | Extended-release formulation for reducing the frequency of urination and method of use thereof | |
| MX363993B (es) | Composiciones farmaceuticas con actividad hidratante y lubricante. | |
| CR20160155A (es) | Tienouracilcarboxamidas cíclicas y usos de las mismas | |
| MY160377A (en) | Topical pharmaceutical compositions | |
| AR083095A1 (es) | Cocristal de aprepitant l-prolina y composicion farmaceutica | |
| AR052322A1 (es) | Compuestos de n-benzoil-estaurosporina, procesos para su preparacion y composicion farmaceutica | |
| JP2011157392A5 (de) | ||
| HK1209027A1 (en) | Vesicular formulations, uses and methods | |
| AR067320A1 (es) | Composicion farmaceutica que comprende la combinacion de un agente antimicrobiano y un agente antioxidante para el tratamiento de infecciones urinarias | |
| GB201007446D0 (en) | Composition for treatment of H.pylori |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |